V

Vericel Corp
D

VCEL

38.275
USD
0.08
(0.20%)
مغلق
حجم التداول
15,768
الربح لكل سهم
1
العائد الربحي
-
P/E
147
حجم السوق
1,935,720,845
أصول ذات صلة المقالات

العنوان: Vericel Corp

القطاع: Healthcare
الصناعة: Biotechnology
Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.